U.S., Feb. 12 -- ClinicalTrials.gov registry received information related to the study (NCT07403825) titled 'Efficacy of Faricimab in Patients With Subretinal Hyper-reflective Material' on Feb. 04.
Brief Summary: Whose aim is to:
Determine the percentage of patients with resolution of subretinal hyperreflective material (SHRM) at week 16.
This study is intended to be performed in the ophthalmology departments or ophthalmology clinics of the participating sites, located in Spain.
Macular degeneration is an eye disease characterised by progressive damage to the macula leading to a loss of central vision. There are two types of macular degeneration, dry and wet or exudative. The prevalence of the latter in Spain is 1.9% in people aged 65 a...